Market Cap 465.02B
Revenue (ttm) 61.16B
Net Income (ttm) 4.23B
EPS (ttm) N/A
PE Ratio 25.21
Forward PE 18.15
Profit Margin 6.91%
Debt to Equity Ratio -11.02
Volume 6,403,004
Avg Vol 7,018,414
Day's Range N/A - N/A
Shares Out 1.77B
Stochastic %K 73%
Beta 0.30
Analysts Strong Sell
Price Target $264.93

Company Profile

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. It also provides...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 847 932 7900
Address:
1 North Waukegan Road, North Chicago, United States
clan
clan Jul. 30 at 10:33 PM
$JNJ $ABBV $GSK If you know Dry Powder Inhalation (DPI), you know it's great for all Mannkind. 🚫💉
0 · Reply
Oldpuck
Oldpuck Jul. 30 at 8:21 PM
$ABBV not the way you like to head into earnings
0 · Reply
judgeyoung2
judgeyoung2 Jul. 30 at 7:55 PM
$ABBV @cubie thoughts on the far otm far dated puts ?
0 · Reply
profit_guru
profit_guru Jul. 30 at 7:52 PM
$ABBV - if they miss earnings it will open beliw 230…imo
0 · Reply
ra1980
ra1980 Jul. 30 at 7:51 PM
$UNH $ELV $ABBV $MCK $MDLN if the tech sector rises again it will be good idea to short health sector
0 · Reply
DidYouReadThis
DidYouReadThis Jul. 30 at 7:50 PM
$OTLK Do you know what a #14d9 is? Do you think there could possibly be one within 2 weeks-20 years? ​$NVS $ABBV $REGN
0 · Reply
ra1980
ra1980 Jul. 30 at 7:43 PM
$ABBV short some here🤢🤢🤢 Hope no fuck tomorrow
0 · Reply
Wstb100
Wstb100 Jul. 30 at 7:35 PM
$ABBV shall one short prior to earnings.
1 · Reply
Stockman824
Stockman824 Jul. 30 at 7:28 PM
$ABBV $LLY $MRK $PFE $VKTX I agree 100% and as @ihsvenoidea will back me up. We were in Arena Pharmaceuticals with quite possibly THE WORST Slimiest CEO ever but we got bought out for 100 by Pfizer after a 1/10 rs he was truly awful but Arenas SCIENCE was BEST IN CLASS by far. It always comes down to the SCIENCE. Hopefully we get a really strong BP partnership and they take over a lot of the calls. We can EASILY become a 500+ company in a few years
0 · Reply
maphere
maphere Jul. 30 at 7:01 PM
$RGNX $ABBV Place your bets whether Abbvie finally discusses the 314 program tomorrow. Big reveal EOY which could move into a BLA 1Q27 for a global wAMD program...and as suggested before, are they going for SOC which is a big jump to getting a small percentage due to the SR delivery to this is better than SOC treatment. Does RGNX PR their ER tomorrow as well and hint towards FDA nod on 121? Nice to have 3 solid catalysts, 2 of which are substantial indications that could propel this stock much higher.
0 · Reply
Latest News on ABBV
JUVÉDERM® Day Returns to U.S. on August 19

Jul 30, 2026, 8:00 AM EDT - 10 hours ago

JUVÉDERM® Day Returns to U.S. on August 19


AbbVie announces Elahere availability in Singapore

2026-07-29T09:30:43.000Z - 1 day ago

AbbVie announces Elahere availability in Singapore


AbbVie announces European Commission approval for Rinvoq

2026-07-29T09:15:30.000Z - 1 day ago

AbbVie announces European Commission approval for Rinvoq


AbbVie price target raised to $300 from $275 at Barclays

2026-07-29T09:10:59.000Z - 1 day ago

AbbVie price target raised to $300 from $275 at Barclays


AbbVie price target raised to $282 from $273 at Canaccord

2026-07-22T10:40:12.000Z - 8 days ago

AbbVie price target raised to $282 from $273 at Canaccord


AbbVie price target raised to $260 from $230 at Citi

2026-07-15T10:21:06.000Z - 15 days ago

AbbVie price target raised to $260 from $230 at Citi


AbbVie price target raised to $260 from $230 at UBS

2026-07-13T16:30:09.000Z - 17 days ago

AbbVie price target raised to $260 from $230 at UBS


AbbVie price target raised to $300 from $258 at BMO Capital

2026-07-13T12:27:09.000Z - 17 days ago

AbbVie price target raised to $300 from $258 at BMO Capital


AbbVie price target raised to $280 from $260 at RBC Capital

2026-07-10T13:10:21.000Z - 20 days ago

AbbVie price target raised to $280 from $260 at RBC Capital


AbbVie price target raised to $276 from $234 at BofA

2026-07-10T10:31:16.000Z - 20 days ago

AbbVie price target raised to $276 from $234 at BofA


AbbVie price target raised to $295 from $260 at Wells Fargo

2026-07-10T10:20:22.000Z - 20 days ago

AbbVie price target raised to $295 from $260 at Wells Fargo


AbbVie price target raised to $280 from $260 at JPMorgan

2026-07-09T12:06:14.000Z - 21 days ago

AbbVie price target raised to $280 from $260 at JPMorgan


AbbVie price target raised to $261 from $249 at Guggenheim

2026-07-09T11:30:42.000Z - 21 days ago

AbbVie price target raised to $261 from $249 at Guggenheim


AbbVie says Q2 EPS to include unfavorable impact of 17c

2026-07-06T20:20:39.000Z - 24 days ago

AbbVie says Q2 EPS to include unfavorable impact of 17c


AbbVie to Host Second-Quarter 2026 Earnings Conference Call

Jun 26, 2026, 8:00 AM EDT - 4 weeks ago

AbbVie to Host Second-Quarter 2026 Earnings Conference Call


AbbVie's $11 Billion Immunology Bet

Jun 24, 2026, 12:51 PM EDT - 5 weeks ago

AbbVie's $11 Billion Immunology Bet

APGE


AbbVie to Buy Apogee Therapeutics for $10.9 Billion

Jun 22, 2026, 10:15 AM EDT - 5 weeks ago

AbbVie to Buy Apogee Therapeutics for $10.9 Billion

APGE


AbbVie Transcript: M&A announcement

Jun 22, 2026, 9:00 AM EDT - 5 weeks ago

AbbVie Transcript: M&A announcement


AbbVie Slides: M&A announcement

Jun 22, 2026, 9:00 AM EDT - 5 weeks ago

AbbVie Slides: M&A announcement


AbbVie Press release: M&A announcement

Jun 22, 2026, 9:00 AM EDT - 5 weeks ago

AbbVie Press release: M&A announcement


AbbVie to Buy Apogee Therapeutics for $10.9 Billion in Cash

Jun 22, 2026, 7:42 AM EDT - 5 weeks ago

AbbVie to Buy Apogee Therapeutics for $10.9 Billion in Cash

APGE


AbbVie strikes $10.9 billion deal for Apogee Therapeutics

Jun 22, 2026, 7:04 AM EDT - 5 weeks ago

AbbVie strikes $10.9 billion deal for Apogee Therapeutics

APGE


AbbVie Declares Quarterly Dividend

Jun 18, 2026, 4:05 PM EDT - 6 weeks ago

AbbVie Declares Quarterly Dividend


US FDA approves AbbVie's rare blood cancer drug

May 27, 2026, 3:33 PM EDT - 2 months ago

US FDA approves AbbVie's rare blood cancer drug


AbbVie Transcript: AGM 2026

May 8, 2026, 10:00 AM EDT - 2 months ago

AbbVie Transcript: AGM 2026


clan
clan Jul. 30 at 10:33 PM
$JNJ $ABBV $GSK If you know Dry Powder Inhalation (DPI), you know it's great for all Mannkind. 🚫💉
0 · Reply
Oldpuck
Oldpuck Jul. 30 at 8:21 PM
$ABBV not the way you like to head into earnings
0 · Reply
judgeyoung2
judgeyoung2 Jul. 30 at 7:55 PM
$ABBV @cubie thoughts on the far otm far dated puts ?
0 · Reply
profit_guru
profit_guru Jul. 30 at 7:52 PM
$ABBV - if they miss earnings it will open beliw 230…imo
0 · Reply
ra1980
ra1980 Jul. 30 at 7:51 PM
$UNH $ELV $ABBV $MCK $MDLN if the tech sector rises again it will be good idea to short health sector
0 · Reply
DidYouReadThis
DidYouReadThis Jul. 30 at 7:50 PM
$OTLK Do you know what a #14d9 is? Do you think there could possibly be one within 2 weeks-20 years? ​$NVS $ABBV $REGN
0 · Reply
ra1980
ra1980 Jul. 30 at 7:43 PM
$ABBV short some here🤢🤢🤢 Hope no fuck tomorrow
0 · Reply
Wstb100
Wstb100 Jul. 30 at 7:35 PM
$ABBV shall one short prior to earnings.
1 · Reply
Stockman824
Stockman824 Jul. 30 at 7:28 PM
$ABBV $LLY $MRK $PFE $VKTX I agree 100% and as @ihsvenoidea will back me up. We were in Arena Pharmaceuticals with quite possibly THE WORST Slimiest CEO ever but we got bought out for 100 by Pfizer after a 1/10 rs he was truly awful but Arenas SCIENCE was BEST IN CLASS by far. It always comes down to the SCIENCE. Hopefully we get a really strong BP partnership and they take over a lot of the calls. We can EASILY become a 500+ company in a few years
0 · Reply
maphere
maphere Jul. 30 at 7:01 PM
$RGNX $ABBV Place your bets whether Abbvie finally discusses the 314 program tomorrow. Big reveal EOY which could move into a BLA 1Q27 for a global wAMD program...and as suggested before, are they going for SOC which is a big jump to getting a small percentage due to the SR delivery to this is better than SOC treatment. Does RGNX PR their ER tomorrow as well and hint towards FDA nod on 121? Nice to have 3 solid catalysts, 2 of which are substantial indications that could propel this stock much higher.
0 · Reply
biolover
biolover Jul. 30 at 6:23 PM
$VKTX SP will partially correct by last hour. It is becoming obvious. $LLY TZP will generate more than whole $PFE and $MRK this year. Likely more than whole $ABBV BL stupidity on ECs will not matter long term.
0 · Reply
eWhispers
eWhispers Jul. 30 at 5:08 PM
#earnings before the open on Friday, July 31, 2026 https://www.earningswhispers.com/calendar $XOM $ABBV $CCJ $CVX $MRNA
0 · Reply
HydrogenH2
HydrogenH2 Jul. 30 at 4:45 PM
$ABBV Sell the news is on the way.... Here why... https://www.youtube.com/watch?v=INIYTUFZNgg
0 · Reply
JEDI_2023
JEDI_2023 Jul. 30 at 4:25 PM
$XLV $ABBV $GILD $LLY New F up ti hurt GOP as the Trump admin screws over part D Medicare. And holders of these ….. #midterms
0 · Reply
senseidragon
senseidragon Jul. 30 at 4:11 PM
$LLY this is gonna pump hard tomorrow with sympathy er with $ABBV
0 · Reply
HydrogenH2
HydrogenH2 Jul. 30 at 4:08 PM
$ABBV Double Top ??
0 · Reply
27R
27R Jul. 30 at 3:27 PM
$ABBV Buckle up — earnings before the open tomorrow.
1 · Reply
GreenEnergy7B
GreenEnergy7B Jul. 30 at 12:43 PM
$ALT The benefit of GLP1 Glucagon is in addition to weight loss - it is beneficial for MASH and or AUD patients $LLY $AZN $RHHBY $ABBV
0 · Reply
focafoca99
focafoca99 Jul. 30 at 12:15 PM
$ABBV celebrates JUVÉDERM Day return on Aug 19 with exclusive BOGO gift cards and double points for Allé members. https://www.rapidticker.com/news/abbv-juvéderm-day-returns-to-us-681def
0 · Reply
GoforProMIS
GoforProMIS Jul. 30 at 11:33 AM
$PMN buyout candidates are also $ABBV $TEVA $$AMRX for Parkinson
0 · Reply
Quantumup
Quantumup Jul. 30 at 11:06 AM
H.C. Wainwright⬆️ $CORT's PT to $165, reit'd Buy and said -- On July 29, Corcept reported 2Q26 results and provided a corporate update; results were ahead of expectations on multiple fronts. $ABBV $MRK RHHBY AZN DSNKY LLY Here's what else H.C. Wainwright had to say: https://x.com/Quantumup1/status/2082784675450253570?s=20
0 · Reply
BullionBeacon
BullionBeacon Jul. 30 at 8:33 AM
$ABBV Diversified biopharma; managing post-patent-cliff transition with newer immunology drugs picking up growth, steady dividend payer.
0 · Reply